Alicia-Jay J Esposo, NP
Nurse Practitioner · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Alicia-Jay J Esposo’s office at (408) 217-6404 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence C55173 · Cancelled
Licence status: Cancelled · since 2012 · Indiana University School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$18,780
Medicare paid this office $18,780 for 300 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Anticoagulant management of patient taking warfarin | 284 | $11,299 | $9 |
| Short return visit (20+ min) | 46 | $2,771 | $58 |
| Telephone medical discussion with physician, 21-30 minutes | 26 | $2,413 | $93 |
| Return visit (30+ min) | 12 | $1,172 | $98 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $909 | $65 |
Who their Medicare patients are
300 Original Medicare patients in 2024. Average age 79 · Women 47% · Also on Medicaid 14% · Health risk score 1.56. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Atrial fibrillation 75% · Heart failure 44% · Coronary heart disease 35% · Chronic kidney disease 28% · Diabetes 26% · Depression 18% · COPD 15% · Cancer 14% · Stroke 10% · Dementia 8%.
The office billed $87,763, Medicare allowed $24,921 and paid $18,780; for 1,423 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 300 | 1,423 | 79 | 1.56 | $87,763 | $18,780 |
| 2023 | 139 | 168 | 74 | 0.80 | $32,688 | $9,078 |
| 2022 | 283 | 329 | 76 | 0.91 | $32,539 | $14,986 |
| 2021 | 221 | 228 | 74 | 0.88 | $18,394 | $11,258 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Short return visit (20+ min) | 116 | $7,091 | $61 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 12 | $899 | $75 |
| Administration of influenza virus vaccine | 13 | $418 | $32 |
2022: 7 services
| Short return visit (20+ min) | 63 | $4,138 | $64 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 50 mcg/0.25ml dosage, booster dose | 71 | $3,013 | $42 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 33 | $2,318 | $70 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; first dose | 27 | $1,110 | $41 |
| Administration of influenza virus vaccine | 34 | $1,076 | $32 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 40 | $1,034 | $25 |
| Adm sarscv2 bvl 50mcg/.5ml a | 20 | $840 | $42 |
2021: 9 services
| Influenza vaccine split virus, preservative free | 44 | $2,871 | $65 |
| Short return visit (20+ min) | 33 | $2,377 | $70 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; first dose | 22 | $950 | $43 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; third dose | 22 | $949 | $43 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; booster dose | 19 | $806 | $42 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 29 | $783 | $25 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; third dose | 18 | $777 | $43 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 50 mcg/0.25ml dosage, booster dose | 15 | $637 | $42 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; second dose | 12 | $508 | $42 |
Medicaid work
$137,123 in 2021
Medicaid paid $137,123 for 1,744 billed services this clinician did in 2021, up to 124 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 662 | $137,123 |
| Short return visit | 833 | $0 |
| Short return visit (20+ min) | 249 | $0 |
| 2021 | 1,744 | 3 | 124 | $137,123 |
| 2020 | 1,669 | 4 | 115 | $132,415 |
| 2019 | 57 | 1 | 24 | $12,140 |
| 2018 | 322 | 1 | 135 | $64,128 |
See the largest Medicaid services in earlier years
2020
| Clinic visit/encounter, all-inclusive | 669 | $132,319 |
| Short return visit | 238 | $96 |
| Short return visit (20+ min) | 644 | $0 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 118 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 57 | $12,140 |
2018
| Clinic visit/encounter, all-inclusive | 322 | $64,128 |
Drugs they prescribed that Part D paid
$12,383
Pharmacies billed $12,383 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 278) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
268 generic and fewer than 11 brand-name prescriptions · $12,383 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Warfarin | 102 | $3,233 | $13 |
| Enoxaparin | 12 | $1,865 | $124 |
Year by year
| 2024 | 278 | 116 | 0% (0) | None | $12,383 |
| 2023 | 114 | 86 | 0% (0) | 11% | $2,468 |
| 2022 | 66 | 52 | 0% (0) | None | $1,513 |
| 2021 | 591 | 84 | None | None | $22,251 |
| 2020 | 891 | 104 | 2% (14) | 8% | $25,326 |
| 2019 | 761 | 106 | 2% (16) | None | $25,553 |
| 2018 | 293 | 66 | None | 14% | $9,278 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Albuterol Sulfate Hfa | 11 | $312 | $28 |
2021: 17 drugs
| Atorvastatin | 61 | $868 | $14 |
| Albuterol Sulfate Hfa | 11 | $493 | $45 |
| Gabapentin | 25 | $397 | $16 |
| Losartan | 26 | $377 | $15 |
| Amlodipine Besylate | 48 | $297 | $6 |
| Benazepril | 23 | $259 | $11 |
| Sertraline | 15 | $247 | $16 |
| Pravastatin | 13 | $240 | $18 |
| Famotidine | 22 | $213 | $10 |
| Lisinopril | 29 | $168 | $6 |
| Metformin | 18 | $146 | $8 |
| Alendronate | 13 | $124 | $10 |
| Ibuprofen | 23 | $122 | $5 |
| Tamsulosin | 17 | $113 | $7 |
| Lisinopril-Hydrochlorothiazide | 14 | $94 | $7 |
| Omeprazole | 12 | $88 | $7 |
| Trazodone | 15 | $79 | $5 |
2020: 23 drugs
| Atorvastatin | 79 | $1,133 | $14 |
| Losartan | 41 | $570 | $14 |
| Pravastatin | 28 | $411 | $15 |
| Oxycodone-Acetaminophen | 12 | $408 | $34 |
| Albuterol Sulfate Hfa | 11 | $398 | $36 |
| Gabapentin | 26 | $356 | $14 |
| Amlodipine Besylate | 63 | $310 | $5 |
| Lisinopril | 50 | $280 | $6 |
| Alendronate | 27 | $273 | $10 |
| Levothyroxine | 16 | $271 | $17 |
| Diclofenac | 13 | $269 | $21 |
| Ibuprofen | 29 | $242 | $8 |
| Famotidine | 26 | $230 | $9 |
| Fluticasone Propionate | 19 | $193 | $10 |
| Metformin | 33 | $192 | $6 |
| Omeprazole | 20 | $190 | $9 |
| Sertraline | 18 | $173 | $10 |
| Benazepril | 17 | $159 | $9 |
| Lisinopril-Hydrochlorothiazide | 26 | $147 | $6 |
| Hydrochlorothiazide | 19 | $146 | $8 |
| Carvedilol | 11 | $123 | $11 |
| Paroxetine | 11 | $112 | $10 |
| Trazodone | 26 | $68 | $3 |
2019: 20 drugs
| Atorvastatin | 83 | $1,177 | $14 |
| Pravastatin | 17 | $468 | $28 |
| Losartan | 41 | $382 | $9 |
| Metformin | 53 | $370 | $7 |
| Gabapentin | 15 | $364 | $24 |
| Amlodipine Besylate | 51 | $318 | $6 |
| Oxycodone-Acetaminophen | 12 | $315 | $26 |
| Lisinopril | 38 | $240 | $6 |
| Levothyroxine | 11 | $217 | $20 |
| Alendronate | 18 | $176 | $10 |
| Ranitidine | 18 | $145 | $8 |
| Hydrochlorothiazide | 28 | $145 | $5 |
| Omeprazole | 15 | $139 | $9 |
| Pioglitazone | 14 | $114 | $8 |
| Fluticasone Propionate | 12 | $113 | $9 |
| Benazepril | 19 | $108 | $6 |
| Famotidine | 19 | $100 | $5 |
| Glipizide | 12 | $80 | $7 |
| Ibuprofen | 11 | $80 | $7 |
| Lisinopril-Hydrochlorothiazide | 20 | $67 | $3 |
2018: 5 drugs
| Atorvastatin | 29 | $398 | $14 |
| Levothyroxine | 11 | $149 | $14 |
| Lisinopril | 15 | $108 | $7 |
| Ibuprofen | 14 | $86 | $6 |
| Lisinopril-Hydrochlorothiazide | 11 | $15 | $1 |
Professional record
- NPI
- 1235647298
- Licence
- CA 55173, CA 95008297California C55173: Cancelled
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X); Physician assistant (363A00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2018-01-11
- NPI last updated
- 2025-03-13
- NPI record certified
- 2025-03-13
This is when the NPI record was last certified, not a medical board exam.